----item----
version: 1
id: {9257846B-D3C9-4D5F-AF2B-3EB1504BFC81}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/01/23/CHMP OK for Santens Ikervis in severe keratitis
parent: {D24B68DA-F9CC-4001-96E8-34149E888C8C}
name: CHMP OK for Santens Ikervis in severe keratitis
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: e3d27d65-0300-4e36-869f-7653f61757ae

----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 48

CHMP OK for Santen's Ikervis in severe keratitis
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 47

CHMP OK for Santens Ikervis in severe keratitis
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 1098

<p>The European Medicines Agency's CHMP has given Santen's Ikervis (ciclosporin) a positive opinion for severe keratitis in adult patients with dry eye disease that has not improved despite treatment with tear substitutes.</p><p>Ciclosporin is an immunosuppressant that blocks the release of pro-inflammatory cytokines and exerts an anti-inflammatory effect in ocular surface cells. Its benefits are that it can improve ocular surface damage and reduce inflammation in DED patients with severe keratitis. This is thought to help prevent disease progression and worsening. The most common side effects of the product are eye pain, eye irritation, lacrimation, ocular hyperaemia and eyelid erythema. Treatment with the drug must be initiated by a professional qualified in ophthalmology.</p><p>Ciclosporin also has a number of orphan designations, including the treatment of moderate and severe closed traumatic brain injury; treatment of herpes simplex virus stromal keratitis; treatment of vernal keratoconjunctivitis; and prevention of graft rejection after lung transplantation, among others.</p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 226

<p>The European Medicines Agency's CHMP has given Santen's Ikervis (ciclosporin) a positive opinion for severe keratitis in adult patients with dry eye disease that has not improved despite treatment with tear substitutes.</p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 47

CHMP OK for Santens Ikervis in severe keratitis
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20150123T174313
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20150123T174313
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20150123T174313
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC027610
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 48

CHMP OK for Santen's Ikervis in severe keratitis
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{CB0FF25D-C5DE-4545-8944-A73FC9496B9B}
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

356249
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042238Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

e3d27d65-0300-4e36-869f-7653f61757ae
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042238Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
